نتایج جستجو برای: fingolimod fty720

تعداد نتایج: 1720  

Journal: :Journal of lipid research 2014
Hideru Obinata Sarah Gutkind Jeremiah Stitham Toshiaki Okuno Takehiko Yokomizo John Hwa Timothy Hla

Sphingosine 1-phosphate receptor 1 (S1P₁), an abundantly-expressed G protein-coupled receptor which regulates key vascular and immune responses, is a therapeutic target in autoimmune diseases. Fingolimod/Gilenya (FTY720), an oral medication for relapsing-remitting multiple sclerosis, targets S1P₁ receptors on immune and neural cells to suppress neuroinflammation. However, suppression of endothe...

2011
Kiyoaki Yonesu Kazuishi Kubota Masakazu Tamura Shin-ichi Inaba Tomohiro Honda Chizuko Yahara Nobuaki Watanabe Tatsuji Matsuoka Futoshi Nara

CS-0777 is a selective sphingosine 1-phosphate (S1P) receptor 1 modulator with potential benefits in the treatment of autoimmune diseases, including multiple sclerosis. CS-0777 is a prodrug that requires phosphorylation to an active S1P analog, similar to the first-in-class S1P receptor modulator FTY720 (fingolimod). We sought to identify the kinase(s) involved in phosphorylation of CS-0777, an...

2013
Noriyasu Seki Yasuhiro Maeda Hirotoshi Kataoka Kunio Sugahara Kenji Chiba

Infiltration of myelin-specific helper T (Th) cells into the central nervous system (CNS) plays a key role in pathogenesis of experimental autoimmune encephalomyelitis (EAE). In this study, we investigated the involvement of sphingosine 1-phosphate (S1P)-S1P receptor 1 (S1P1) axis in lymphocytes for EAE development when C57BL/6 mice were immunized with myelin oliogodendrocyte glycoprotein (MOG)...

2014
Pedro J. Gonzalez-Cabrera Steve Brown Sean M. Studer Hugh Rosen

Development of sphingosine-1-phosphate receptor 1 (S1P1) modulators to dampen inflammation and its sequelae is becoming increasingly promising for treating medical conditions characterized by significant immunopathology. As shown by the non-selective S1P receptor modulator FTY720 (fingolimod [Gilenya(®)]) in the treatment of relapsing-remitting multiple sclerosis (MS), the ability to use S1P1 m...

Journal: :Journal of leukocyte biology 2016
Hai B Tran Jameel Barnawi Miranda Ween Rhys Hamon Eugene Roscioli Greg Hodge Paul N Reynolds Stuart M Pitson Lorena T Davies Rainer Haberberger Sandra Hodge

Alveolar macrophages from chronic obstructive pulmonary disease patients and cigarette smokers are deficient in their ability to phagocytose apoptotic bronchial epithelial cells (efferocytosis). We hypothesized that the defect is mediated via inhibition of sphingosine kinases and/or their subcellular mislocalization in response to cigarette smoke and can be normalized with exogenous sphingosine...

2017
Luca Piali Magdalena Birker-Robaczewska Cyrille Lescop Sylvie Froidevaux Nicole Schmitz Keith Morrison Christopher Kohl Markus Rey Rolf Studer Enrico Vezzali Patrick Hess Martine Clozel Beat Steiner Martin H Bolli Oliver Nayler

Sphingosine-1-phosphate receptor 1 (S1P1 ) modulators sequester circulating lymphocytes within lymph nodes, thereby preventing potentially pathogenic autoimmune cells from exiting into the blood stream and reaching inflamed tissues. S1P1 receptor modulation may thus offer potential to treat various autoimmune diseases. The first nonselective S1P1-5 receptor modulator FTY720/fingolimod/Gilenya® ...

2011
Perry C. Kennedy Ran Zhu Tao Huang Jose L. Tomsig Thomas P. Mathews Marion David Olivier Peyruchaud Timothy L. Macdonald Kevin R. Lynch

Sphingosine 1-phosphate (S1P) is a phospholipid that binds to a set of G proteincoupled receptors (S1P1 – S1P5) to initiate an array of signaling cascades that impact cell survival, differentiation, proliferation, and migration. On a larger physiological scale, the effects of S1P on immune cell trafficking, vascular barrier integrity, angiogenesis, and heart rate have also been observed. An imp...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید